Women with high levels of insulin-like growth factor 1 (IGF-1) may be at increased risk for breast cancer, according to results of a study that used both epidemiological techniques as well as genetic ...

November 26, 2008 — Results of a randomized trial have shown no benefit of treatment with insulinlike growth-factor type 1 (IGF-1) in slowing progression of disease, compared with placebo, among ...

Levels of the hormone increase with disease severity, a new study has found. Plasma levels of insulin-like growth factor 1 (IGF-1) could give clinicians a better understanding of whether a patient ...

Now UAB researchers, led by Guanlan Xu, Ph.D., and Shalev drilled down further into the mechanism underlying verapamil’s beneficial effect. In a paper published in Diabetes, they show that, in Type 1 ...

Results from the ProtecT trial—the largest study to date investigating the link between circulating insulin-like growth factors (IGFs) and prostate cancer—convincingly refute a much-debated role for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The PATHFNDR-2 trial enrolled adults with acromegaly who ...

A growth hormone called insulin-like growth factor-1 (IGF-1) is likely to play a role in the development of breast cancer, according to new research published in the leading cancer journal Annals of ...

Since its discovery over 50 years ago, the biological aspects of insulin-like growth factor-1 (IGF-1) have been determined to be extensive. Ranging from cell proliferation, cell differentiation and ...

Seurat Therapeutics, Inc. (Seurat) announced today the publication of preclinical studies of its lead product candidate, intranasal insulin-like growth factor-1 (IGF-1), in a rat model of migraine ...

Increased signaling of the insulin-like growth factor (IGF) system via alterations in expression levels of its components has been demonstrated in various tumor types. Numerous experimental studies ...